MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/liv.14265

Медицинская библиотека · Liver international : official journal of the International Association for the Study of the Liver · 2019

Gene signature-MELD score and alcohol relapse determine long-term prognosis of patients with severe alcoholic hepatitis.

Deltenre Pierre, Trépo Eric, Fujiwara Naoto, Goossens Nicolas, Marot Astrid, Dubois Margaux, Spahr Laurent, Henrion Jean, Moreno Christophe, Hoshida Yujin

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПоддержка правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

The gene-signature-model for end stage liver disease (gs-MELD) score has been shown to be a strong predictor of 6-month survival in severe alcoholic hepatitis (AH). Currently, only a few studies have evaluated the long-term prognosis of patients with severe AH.

AIM: To assess the prognostic value of the gs-MELD score at 5 years in patients with severe AH.

METHODS

Forty-eight consecutive patients with AH (25 males, median age 52 years [95% IC: 48-56]) were included.

RESULTS

The median gs-MELD score was 2.6 (95% CI: 2.2-3.0). According to the gs-MELD score, 22 patients (46%) were considered to have a poor prognosis. During a median follow-up of 29 months (95% CI: 4-43), 19 patients (40%) were abstinent and 24 patients (50%) died. At 5 years, rates of survival were 61% (95% CI: 41-81) and 26% (95% CI: 11-55) in patients with low and high gs-MELD scores (P = .001), and 81% (95% CI: 58-96) and 22% (95% CI: 10-47) in abstainers and in consumers (P < .001) respectively. In multivariable competing risk regression modelling, gs-MELD score (subdistribution hazard ratio: 5.78, 95% CI: 2.17-15.38, P < .001) and recurrent alcohol consumption (subdistribution hazard ratio: 12.18, 95% CI: 3.16-46.95, P < .001) were independently associated with 5-year mortality.

CONCLUSIONS

Both gs-MELD score and alcohol consumption drive AH long-term prognosis. The gs-MELD score may guide the development of molecularly targeted therapies in AH.

Для цитирования: Deltenre Pierre, Trépo Eric, Fujiwara Naoto, Goossens Nicolas, Marot Astrid, Dubois Margaux, Spahr Laurent, Henrion Jean, Moreno Christophe, Hoshida Yujin. Gene signature-MELD score and alcohol relapse determine long-term prognosis of patients with severe alcoholic hepatitis.. Liver international : official journal of the International Association for the Study of the Liver. 2019. DOI: 10.1111/liv.14265.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.